K-numberK250431
Device nameMedical Diode Laser Hair Removal System (MNLT-D1)
ApplicantShandong Moonlight Electronics Tech Co., Ltd.
Product codeGEX
Device classClass II
Decision dateMay 12, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Medical Diode Laser Hair Removal System (MNLT-D1) is a Class II medical device that uses an 808nm semiconductor diode laser to remove hair and achieve permanent hair reduction across all skin types (Fitzpatrick I-VI), including tanned skin. It operates on the principle of selective photothermolysis, where laser energy is absorbed by melanin in hair follicles, converting optical energy to heat to restrain hair follicle tissues.

Technological characteristics

The proposed device uses an 808nm diode laser with a spot size of 12mm × 21mm, fluence range of 1–65 J/cm², frequency of 1–10 Hz, and pulse duration of 10–320ms. Minor differences from the predicate include slightly different spot size (vs. 12.6mm × 20.6mm), fluence range (vs. 1–70 J/cm²), pulse duration lower bound (vs. 3–320ms), and different power supply/dimensions/weight specifications, none of which affect therapeutic function.

Test standards cited

The device was tested to IEC 60601-1:2020 (medical electrical equipment general safety), IEC 60601-1-2:2020 (EMC), IEC 60601-2-22:2012 (laser equipment), IEC 60825-1:2007 (laser safety), ISO 10993-5:2009 (cytotoxicity), ISO 10993-10:2021 (skin sensitization), and ISO 10993-23:2021 (irritation). No clinical study was conducted.

Substantial equivalence argument

The proposed device is substantially equivalent because it shares the same product code (GEX), regulatory classification (Class II, 21 CFR 878.4810), intended indications for use, configuration (main unit, handpiece, foot control), and principle of operation (808nm diode laser) as the predicate K221312. All measured differences (spot size, fluence, pulse duration, power supply, dimensions, weight, and updated testing standards) are either within the predicate's parameter ranges or are physical/administrative variations that do not raise new safety or effectiveness concerns, as demonstrated by nonclinical testing to FDA-recognized standards and biocompatibility testing showing no cytotoxicity, sensitization, or irritation.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →